Singapore Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Singaporean pharmaceuticals market had total revenues of $12.9 billion in 2022, representing a compound annual growth rate (CAGR) of 2.5% between 2017 and 2022.
- 0
- The Singaporean market acquired a 3% share of the Asia-Pacific pharmaceuticals market in 2022. Singapore, a leading biomedical and pharmaceutical hub in Asia, has been attracting foreign and private investors through its Biomedical Sciences initiative since 2000. The government's support, including funding research and development, has also contributed to the industry's growth.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Singapore pharmaceuticals market by value in 2022?
- What will be the size of the Singapore pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Singapore's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Novartis AG
- 8.2. Pfizer Inc.
- 8.3. GSK plc.
- 8.4. Astellas Pharma Inc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Singapore pharmaceuticals market value: $ billion, 2017-22
- Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Novartis AG: key facts
- Table 5: Novartis AG: Annual Financial Ratios
- Table 6: Novartis AG: Key Employees
- Table 7: Novartis AG: Key Employees Continued
- Table 8: Pfizer Inc.: key facts
- Table 9: Pfizer Inc.: Annual Financial Ratios
- Table 10: Pfizer Inc.: Key Employees
- Table 11: Pfizer Inc.: Key Employees Continued
- Table 12: GSK plc.: key facts
- Table 13: GSK plc.: Annual Financial Ratios
- Table 14: GSK plc.: Key Employees
- Table 15: GSK plc.: Key Employees Continued
- Table 16: Astellas Pharma Inc.: key facts
- Table 17: Astellas Pharma Inc.: Annual Financial Ratios
- Table 18: Astellas Pharma Inc.: Key Employees
- Table 19: Singapore size of population (million), 2018-22
- Table 20: Singapore gdp (constant 2005 prices, $ billion), 2018-22
- Table 21: Singapore gdp (current prices, $ billion), 2018-22
- Table 22: Singapore inflation, 2018-22
- Table 23: Singapore consumer price index (absolute), 2018-22
- Table 24: Singapore exchange rate, 2018-22
- List of Figures
- Figure 1: Singapore pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook